Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors

Clinical trial NCT05887492 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05887492
Sponsor: Tango Therapeutics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Solid Tumors, Adult Lung Cancer Lung Adenocarcinoma

Start date: 2023-06-12
Primary completion: 2026-09-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.